Identification of a potent regulatory T cell epitope infactor V that modulates CD4+ and CD8+ memory T cell responses
FV621 De Groot et al 2021
HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA)
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
